Pharmafile Logo
Pharmafocus logo
Advanced Search

Europe

Showing 15 posts of 198 posts found.

novartis_outside_1

Novartis’ Cosentyx gets European go-ahead in paediatric plaque psoriasis

August 3, 2020
Sales and Marketing Cosentyx, Europe, Novartis, pharma, psoriasis

Novartis’ interleukin-17A (IL-17A) inhibitor Cosentyx (secukinumab) has chalked up approval from the European Commission (EC) for the treatment of patients …

News
novartis_outside_1

Novartis’ Piqray combo becomes first Europe-approved therapy for PIK3CA-mutated advanced breast cancer

July 29, 2020
Research and Development, Sales and Marketing Europe, Novartis, Piqray, breast cancer, pharma

The European Commission (EC) has awarded its approval for Novartis’ Piqray (alpelisib) to be made available in combination with fulvestrant …

News
european_commission_web

European green light for Lynparza in germline BRCA-mutated metastatic pancreatic cancer

July 8, 2020
Research and Development, Sales and Marketing AstraZeneca, Cancer, Europe, MSD, lynparza

The European Commission has awarded approval to AstraZeneca and MSD’s Lynparza (olaparib) for germline BRCA-mutated (gBRCAm) metastatic pancreatic cancer, with …

News
european_commission_web

Europe extends Invokana indication to cover diabetic kidney disease in type 2 diabetes patients

July 3, 2020
Medical Communications, Research and Development Europe, Mundipharma, invokana

European Commission has moved to expand the existing approved indication for Mundipharma’s Invokana (canagliflozin), making it the first sodium glucose co-transporter …

News
shutterstock

EU reportedly in talks with J&J to secure doses of its COVID-19 vaccine

June 19, 2020
Medical Communications, Research and Development, Sales and Marketing COVID-19, EU, Europe, J&J, JJ, Vaccine

It has been reported that the European Union is currently negotiating a deal with pharma giant Johnson & Johnson to …

News

Sanofi’s Sarclisa combo approved in Europe for relapsed/refractory multiple myeloma

June 2, 2020
Manufacturing and Production, Sales and Marketing Europe, Sanofi, Sarclisa, pharma

Sanofi has scored a new approval from the European Commission for the use of its CD38 inhibitor Sarclisa (isatuximab) in …

News
bmssyracuseny

BMS’ Zeposia becomes first S1P receptor modulator available in Europe for relapsing remitting multiple sclerosis

May 28, 2020
Sales and Marketing Avonex, Bristol-Myers Squibb, EU, Europe, Zeposia, bristol myers squibb, multiple sclerosis

Bristol Myers Squibb is celebrating after its oral therapy Zeposia (ozanimod), secured European Commission for the treatment of relapsing remitting …

News

Vertex’s Kalydeco seizes EU CHMP recommendation for Kalydeco in R117H+ cystic fibrosis

May 1, 2020
Medical Communications, Sales and Marketing Europe, Kalydeco, Vertex, cystic fibrosis

The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has given its recommendation for the approval …

News
takeda_usa_pharmaceuticals_u

Takeda’s Alunbrig outclasses Xalkori to secure EU approval in ALK+ advanced non-small cell lung cancer

April 7, 2020
Manufacturing and Production, Sales and Marketing Alunbrig, Europe, Takeda, pharma

The European Commission has ruled to expand the current approved indication of Takeda’s Alunbrig (brigatinib), authorising the drug as a …

News

Bayer’s Nubeqa combo approved in Europe for non-metastatic castration-resistant prostate cancer

March 31, 2020
Manufacturing and Production, Research and Development Bayer, Cancer, Europe, Nubeqa, prostate cancer

The European Commission has given the green light to Bayer’s non-steroidal androgen receptor inhibitor Nubeqa (darolutamide), jointly developed with Orion, …

News
europe-1395916_640

Drug launches across Europe will be affected by coronavirus

March 20, 2020
Medical Communications, Sales and Marketing EU, Europe, coronavirus, pharma

The COVID-19 pandemic will affect European launches of drugs for a host of diseases including HIV, cancer and sickle cell …

News

Ameluz approved by European Commission for treatment for actinic keratosis

March 11, 2020
Research and Development EC, EMA, Europe, Lesions

Biofrontera AG has announced the European Commission has approved the use of their drug Ameluz in combination with photodynamic therapy …

News
top_10_image_2

Top Ten most popular articles on Pharmafile.com this week

February 21, 2020
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug market, Europe, coronavirus, opioid crisis, opioids

The coronavirus is again in the news, with the Indian government considering banning exports of medicine as the epidemic threatens …

News
pfizer-building-logo1web

Europe approves first treatment for transthyretin amyloidosis in cardiomyopathy patients: Pfizer’s Vyndaqel

February 19, 2020
Research and Development, Sales and Marketing Europe, Pfizer, Vyndaqel, pharma, transthyretin amyloidosis

The European Commission (EC) has awarded marketing approval to Pfizer’s Vyndaqel (tafamidis), it has emerged, for the treatment of wild-type …

News
humacao_exterior

BMS pulls Opdivo+Yervoy combo in EU for advanced non-small cell lung cancer

February 3, 2020
Sales and Marketing BMS, Cancer, Europe, Yervoy, lung cancer, opdivo

Bristol-Myers Squibb has confirmed it has withdrawn its application with the European Commission for its combination of Opdivo (nivolumab) and …

News

Latest content

Regeneron shares data for multiple myeloma treatment

December 8, 2023

Merck collaborates with Acceleration Consortium for AI experimentation

December 8, 2023

AbbVie to acquire Cerevel Therapeutics for approximately $8.7bn

December 7, 2023

ONK Therapeutics and NAYA Biosciences enter partnership for NK cell therapy development

December 7, 2023

FDA approves Novartis’ Fabhalta for PNH treatment

December 6, 2023